|
6RO1
X-ray crystal structure of the MTR4 NVL complex
Deposited 2019-05-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
167–216(50 aa)
|
Not recorded
|
SO4 SULFATE ION × 6
ADP ADENOSINE-5'-DIPHOSPHATE × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;0.1M Tris/HCl pH 8.0, 1.8M Ammonium Sulphate
|
Resolution 3.07 Å
R-free 0.257
|
|
9BJI
Cryo-EM structure of apo NVL
Deposited 2024-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–856(856 aa)
Chain B
1–856(856 aa)
Chain C
1–856(856 aa)
Chain D
1–856(856 aa)
Chain E
1–856(856 aa)
Chain F
1–856(856 aa)
|
Mutation:E365Q,E682Q
Mutation:E365Q,E682Q
Mutation:E365Q,E682Q
Mutation:E365Q,E682Q
Mutation:E365Q,E682Q
Mutation:E365Q,E682Q
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 9
MG MAGNESIUM ION × 8
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.83 Å
|
|
9BJJ
Cryo-EM structure of NVL bound the the MM017 inhibitor
Deposited 2024-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–856(856 aa)
Chain B
1–856(856 aa)
Chain C
1–856(856 aa)
Chain D
1–856(856 aa)
Chain E
1–856(856 aa)
Chain F
1–856(856 aa)
|
Mutation:E365Q, E682Q
Mutation:E365Q, E682Q
Mutation:E365Q, E682Q
Mutation:E365Q, E682Q
Mutation:E365Q, E682Q
Mutation:E365Q, E682Q
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 9
MG MAGNESIUM ION × 8
A1AP0 N-[10-(2-methoxyethyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl]furan-3-carboxamide × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.06 Å
|
|
9NYP
Cryo-EM structure of NVL bound the the MM927 inhibitor
Deposited 2025-03-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–856(856 aa)
Chain B
1–856(856 aa)
Chain C
1–856(856 aa)
Chain D
1–856(856 aa)
Chain E
1–856(856 aa)
Chain F
1–856(856 aa)
|
Mutation:E366Q,E683Q
Mutation:E366Q,E683Q
Mutation:E366Q,E683Q
Mutation:E366Q,E683Q
Mutation:E366Q,E683Q
Mutation:E366Q,E683Q
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 9
MG MAGNESIUM ION × 8
ADP ADENOSINE-5'-DIPHOSPHATE × 1
A1B7F N-[10-(but-2-yn-1-yl)-3-fluoro-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl]-3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-5-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.86 Å
|